Ethiodized oil
- Generic Name
- Ethiodized oil
- Brand Names
- Lipiodol, Lipiodol Ultra Fluide
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 8008-53-5
- Unique Ingredient Identifier
- KZW0R0686Q
- Background
Ethiodized oil is used by injection as a radio-opaque contrast agent. The composition of the oil is comprised of iodine combined with ethyl esters of fatty acids of poppyseed oil. And although these esters are primarily as ethyl monoiodostearate and ethyl diiodostearate, the actual, specific structure is unknown.
- Indication
For use as a radio-opaque medium for hysterosalpingography and lymphography, and as an antineoplastic agent when part of the iodine is 131-I. It is also used in follow-up imaging for chemoembolization.
- Associated Conditions
- Hepatocellular Carcinoma
- Associated Therapies
- -
Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma
- Conditions
- Interventions
- First Posted Date
- 2023-05-03
- Last Posted Date
- 2024-02-13
- Lead Sponsor
- VA Office of Research and Development
- Target Recruit Count
- 93
- Registration Number
- NCT05842174
- Locations
- 🇺🇸
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia, Pennsylvania, United States
Transarterial Chemoembolization for the Treatment of Lung Cancer and Lung Metastases
- Conditions
- Interventions
- First Posted Date
- 2023-01-05
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- City of Hope Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT05672108
- Locations
- 🇺🇸
City of Hope Medical Center, Duarte, California, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
Preoperative Embolization of Hypervascular Head and Neck Tumors to Improve Surgical Outcomes
- First Posted Date
- 2022-08-05
- Last Posted Date
- 2023-12-12
- Lead Sponsor
- University of Washington
- Registration Number
- NCT05490381
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
T-ACE Oil by TAE/TACE in Patients With Hepatocellular Carcinoma
- First Posted Date
- 2022-06-28
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- T-ACE Medical Co., Ltd
- Target Recruit Count
- 90
- Registration Number
- NCT05435014
- Locations
- 🇨🇳
Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
🇨🇳Tungs' Taichung Metroharbor Hospital, Taichung, Taiwan
🇨🇳National Cheng Kung University Hospital, Tainan, Taiwan
Pharmacogenetic Study in Hepatocellular Carcinoma Patients.
- First Posted Date
- 2022-03-22
- Last Posted Date
- 2023-07-28
- Lead Sponsor
- Rehab Werida
- Target Recruit Count
- 107
- Registration Number
- NCT05291338
- Locations
- 🇪🇬
Ain Shams University hepatoma group, EL Demerdash Hospital, Cairo, Egypt., Cairo, Egypt
Novel Light Delivery Methods for Lung Cancer Photodynamic Therapy - A Pilot Study
- First Posted Date
- 2021-02-15
- Last Posted Date
- 2021-02-15
- Lead Sponsor
- Taoyuan General Hospital
- Target Recruit Count
- 3
- Registration Number
- NCT04753918
Safety and Efficacy of a Lipiodol Emulsion for the Embolization of Hypervascularizations in Patients With Knee Pain (LipioJoint1)
- First Posted Date
- 2021-02-01
- Last Posted Date
- 2023-08-03
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 22
- Registration Number
- NCT04733092
- Locations
- 🇫🇷
Hôpital européen Georges Pompidou, Paris, France
Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases
- First Posted Date
- 2021-01-28
- Last Posted Date
- 2024-10-23
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 28
- Registration Number
- NCT04728633
- Locations
- 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson Univeristy, Philadelphia, Pennsylvania, United States
Identify Proteomic Biomarkers for Outcome Prediction of Locoregional Treatments for HCC
- First Posted Date
- 2020-07-07
- Last Posted Date
- 2023-12-12
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT04459468
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
Chemoembolization for Lung Tumors
- Conditions
- Interventions
- First Posted Date
- 2019-12-16
- Last Posted Date
- 2022-04-22
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 10
- Registration Number
- NCT04200417
- Locations
- 🇺🇸
Memoral Sloan Kettering Monmouth (Consent only), Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Cancer Center @ Commack (Consent Only), Commack, New York, United States
🇺🇸Memoral Sloan Kettering Westchester (Consent only), Harrison, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.